Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1976 Dec;34(6):655–660. doi: 10.1038/bjc.1976.228

Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.

H C Ho, M H Ng, H C Kwan, J C Chau
PMCID: PMC2025221  PMID: 188437

Abstract

The sera of 73 patients with nasopharyngeal carcinoma (NPC), 28 patients with other carcinomas (OC) and 89 healthy subjects (HS) were tested for IgG and IgA antibodies to Epstein-Barr virus (EBV) viral capsid antigen (VCA). The majority of the NPC sera had IgG titres of 160 or above, whereas the majority of the other sera had titres below 160. For IgA reactivity to EBV-VCA, 68 of 73 (93-2%) NPC sera had titres of greater than or equal to 10. In contrast, only 6 of 28 (21-4%) OC sera and none of the HS sera had such titres. The mean serum concentrations of IgG, IgA, IgM and C3' were also determined in 55 NPC and 20 OC patients and 18 HS. They were all significantly higher in the NPC sera than in the HS. Although the concentrations of IgG and C3' were not significantly different in the two carcinoma groups, the concentrations of IgA and IgM were significantly higher in the NPC group than in OC. These findings appear to reflect the intensity of EBV-specific antigenic stimulation in NPC, and the EBV-specific serum IgA reactivity may be a sueful aid to the diagnosis of NPC, especially in cases with an occult primary tumour. It may be also of value as a screening test in people at high risk.

Full text

PDF
659

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Desgranges C., Wolf H., De-Thé G., Shanmugaratnam K., Cammoun N., Ellouz R., Klein G., Lennert K., Muñoz N., Zur Hausen H. Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int J Cancer. 1975 Jul 15;16(1):7–15. doi: 10.1002/ijc.2910160103. [DOI] [PubMed] [Google Scholar]
  2. Glaser R., de Thé G., Lenoir G., Ho J. H. Superinfection epithelial nasopharyngeal carcinoma cells with Epstein-Barr virus. Proc Natl Acad Sci U S A. 1976 Mar;73(3):960–963. doi: 10.1073/pnas.73.3.960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Henderson B. E., Louie E., Bogdanoff E., Henie W., Alena B., Henie G. Antibodies to herpes group viruses in patients with nasopharyngeal and other head and neck cancers. Cancer Res. 1974 May;34(5):1207–1210. [PubMed] [Google Scholar]
  4. Henle G., Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer. 1976 Jan 15;17(1):1–7. doi: 10.1002/ijc.2910170102. [DOI] [PubMed] [Google Scholar]
  5. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Henle W., Henle G., Ho H. C., Burtin P., Cachin Y., Clifford P., de Schryver A., de-Thé G., Diehl V., Klein G. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst. 1970 Jan;44(1):225–231. [PubMed] [Google Scholar]
  7. Henle W., Ho H. C., Henle G., Kwan H. C. Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases with long-term survivors. J Natl Cancer Inst. 1973 Aug;51(2):361–369. [PubMed] [Google Scholar]
  8. Ho J. H. Nasopharyngeal carcinoma (NPC). Adv Cancer Res. 1972;15:57–92. doi: 10.1016/s0065-230x(08)60372-3. [DOI] [PubMed] [Google Scholar]
  9. Huang D. P., Ho J. H., Henle W., Henle G. Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies. Int J Cancer. 1974 Nov 15;14(5):580–588. doi: 10.1002/ijc.2910140504. [DOI] [PubMed] [Google Scholar]
  10. Klein G., Giovanella B. C., Lindahl T., Fialkow P. J., Singh S., Stehlin J. S. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci U S A. 1974 Dec;71(12):4737–4741. doi: 10.1073/pnas.71.12.4737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Old L. J., Boyse E. A., Oettgen H. F., Harven E. D., Geering G., Williamson B., Clifford P. Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A. 1966 Dec;56(6):1699–1704. doi: 10.1073/pnas.56.6.1699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Trumper P. A., Epstein M. A., Giovanella V. S. Epstein Barr virus and nasopharyngeal carcinoma. Lancet. 1976 Mar 27;1(7961):686–687. doi: 10.1016/s0140-6736(76)92794-x. [DOI] [PubMed] [Google Scholar]
  13. Wara W. M., Wara D. W., Phillips T. L., Ammann A. J. Elevated IGA in carcinoma of the nasopharynx. Cancer. 1975 May;35(5):1313–1315. doi: 10.1002/1097-0142(197505)35:5<1313::aid-cncr2820350510>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  14. Wolf H., Zur Hausen H., Klein G., Becker V., Henle G., Henle W. Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr viral DNA in non-lymphoid nasopharyngeal carcinoma cells. Med Microbiol Immunol. 1975;161(1):15–21. doi: 10.1007/BF02120766. [DOI] [PubMed] [Google Scholar]
  15. Wolf H., zur Hausen H., Becker V. EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol. 1973 Aug 22;244(138):245–247. doi: 10.1038/newbio244245a0. [DOI] [PubMed] [Google Scholar]
  16. de Schryver A., Friberg S., Jr, Klein G., Henle W., Henle G., De-Thé G., Clifford P., Ho H. C. Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space. Clin Exp Immunol. 1969 Nov;5(5):443–459. [PMC free article] [PubMed] [Google Scholar]
  17. de Schryver A., Klein G., Henle W., Henle G. EB virus-associated antibodies in Caucasian patients with carcinoma of the nasopharynx and in long-term survivors after treatment. Int J Cancer. 1974 Mar 15;13(3):319–325. doi: 10.1002/ijc.2910130307. [DOI] [PubMed] [Google Scholar]
  18. de-Thé G., Ho J. H., Ablashi D. V., Day N. E., Macario A. J., Martin-Berthelon M. C., Pearson G., Sohier R. Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other ebv antigens in chinese patients. Int J Cancer. 1975 Nov 15;16(5):713–721. doi: 10.1002/ijc.2910160503. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES